StockTipsArenaBeta

BUY Sun Pharma Advanced Research Company Limited — Ratnesh Goyel, Arihant Capital Markets

BUYSun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company share price target & all analyst calls

byRatnesh Goyel, Arihant Capital MarketsHorizon: 1–3 months7 Jul 2026via Business Today

Entry₹266.7Inferred
Target₹285
Total upside +6.86% (call closed)
Stop loss₹250-6.26% risk
Exit₹2858 Jul 2026, 12:00 am
Target hit+6.86%0.00%upside left
Follow Ratnesh Goyel for new callsGet alertsWatch SPARC for new buy/sell callsGet alertsSee 41 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 7:21 pm IST
0 supporting1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Sun Pharma Advanced Research Company Ltd has announced the termination of a license agreement with CMS Bridging DMCC.

BSE · Company Update·25 Jun · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharma Advanced Research Company

All analyst calls on Sun Pharma Advanced Research Company

More from Ratnesh Goyel, Arihant Capital Markets

Every call and its outcome